Are you a general practitioner?

Advance your professional journey in the world of cardiology and circulatory health at WCC

We encourage you to join us at WCC where you will have access to a special track developed for general practitioners. It will feature sessions like:

Risk stratification & prediction of events

Date: Thursday, 6 December 2018

Chair: Afzal Hussein Yusufali, UAE

Chair: Mekhman Mamedov, Russia

Talk 1 Primary Prevention – risk scoring

Speaker:  Pablo Perel, Switzerland

Talk 2 Post Myocardial Infarction – Who is Safe and Who is Unsafe

Speaker, Country Massoud Ghasemi

Talk 3 Chronic Stable CAD – How Do We Stratify for Risk and Choosing Therapy

Speaker, Country Stefan Achenbach

Talk 4 Should Risk Prediction Paradigms be Different in LMICS

Speaker, Country Tom Gaziano, USA

Stroke prevention in atrial fibrillation

Date: Thursday, 6 December 2018

Chair, Country: Ashley Chin, South Africa

Chair, Country: Jasim Mohamed Al Hashmi, UAE

Talk 1 Is it feasible to reverse the NOAC overdose?

Speaker: Adel Khalifa Hamad, Bahrain

Talk 2 Coronary intervention and AF management: Are the guidelines clear?

Speaker: Nassir Marrouche, USA

Talk 3 Oral anticoagulation in the octogenerians: Is it safe?

Speaker: Ali Oto

Talk 4 Use of anticoagulants in LMIC

Speaker: Ganesan Karthkeyan, India

Management of Hypertension

Date: Friday, 7 December 2018

Chair, Country: Aman Amanullah, Bangladesh

Chair, Country: Mohammad Naeem Aslam, Pakistan

Talk 1 Management of hypertension in pregnancy

Speaker: Natalie Bello, USA

Talk 2 Screening for secondary hypertension

Speaker: Khalida Soomro, Pakistan

Talk 3 Hypertension, Left Ventricular Remodelling and Hypertensive Heart Failure in Black African Patients

Speaker: Dike Ojj, Nigeria

Talk 4 Salt-Sensitive Hypertension in Asia:  Prevalence, Genome, and Novel Therapy

Speaker: Tzung-Dau Wang, Taiwan

Stable CAD

Date: Friday, 7 December 2018

Chair, Country: Mpiko Ntsekhe, South Africa

Chair, Country: Hesham Ahmed Osman, UAE

Talk 1 Role of Ischemia vs. Stenosis in Driving Therapeutic Decisions

Speaker: Sidney C. Smith Jr, USA

Talk 2 What is Optimal Medical Therapy for CAD and What Should Be the Goals

Speaker: Vinay Bahl, India

Talk 3 Diabetes & CAD: Is there a role for PCI?

Speaker: Haitham Amin

Talk 4 Environment and CAD – Pollution, Climate & Stress

Speaker: Daniel Piñeiro, Argentina

 

Practical Approaches to Reduce Cardiovascular Risk Factor

Date: Friday, 7 December 2018

Chair, Country: Andrzej Budaj, Poland

Chair, Country: Ntobeko Ntusi, South Africa

Talk 1 Optimal and Still Practical Ways to Manage Hypertension: What the General Practitioner Needs to do

Speaker: Eugene Yang, USA

Talk 2 Helping Your Patient Becoming Active, Be Compliant with Drugs, and Reduce Stress (general overview in motivational interview, compliance, etc.)

Speaker: Marta Supervia, Spain

Talk 3 Smoking Cessation for Practitioners

Speaker: Ondrej Sochor Czech Republic

Talk 4 How to manage obesity in the office

Speaker: Maria Collazo Puerto Rico

Menopausal Hormone Therapy in The Prevention of Cardiovascular Disease - Debate

Date: Friday, 7 December 2018

Chair, Country: Sharif Bakir

Chair, Country: Mary Walsh

Talk 1 It is vital, only needs a tweak  

Speaker: Jayanthi Jayawardena

Talk 2: It’s waste of time

Speaker: Marildes Castro, Brazil

Controversies in Hypertension

Date: Saturday, 8 December 2018

Chair, Country: Mohammed Zubaid, Kuwait

Chair, Country: Prakash Deedwania

Talk 1 Renal Denervation – From Hero to Zero – and back? Who, when, how?

Speaker:  Deepak Bhatt, USA

Talk 2 One drug, many drugs, low dose, high dose?

Speaker: Clara Chow, Australia

Talk 3 What is the ideal BP?

Speaker:  Victor Huckell, Canada

Real world prevention of stroke in atrial fibrillation: how guidelines are applied

Date: Saturday, 8 December 2018

Chair, Country: Ashley Chin, South Africa

Chair, Country: Koji Hasegawa

Talk 1 The guideline of stroke prevention: all NOACs are same or different?

Speaker: Antoni Martínez-Rubio, Spain

Talk 2 Risk stratification of stroke: more than CHADS and CHA2DS2-Vasc

Speaker: Ali Oto, Turkey

Talk 3 Anti-coagulants in frail, high-aged Asian population

Speaker: Dong (Dede) Zhao, China

Don’t miss this unique educational opportunity

Register now